Pharmaceuticals, Biotechnology and Life Sciences
NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the appointment of accomplished biotech and pharmaceutical executive, Olivi…
SAN DIEGO–(BUSINESS WIRE)–$ALXN #Alexionpharmaceuticals–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines…
– Targeted to Help Accelerate US and Worldwide Drug Discovery and Pre-Clinical R&D
WILMINGTON, Del.–(BUSINESS WIRE)–GemPharmatech (GPT) Co., Ltd. announced the establishment of new operations to house more than 6000 mouse models in Massachusetts…
UTRECHT, The Netherlands & PHILADELPHIA–(BUSINESS WIRE)–LAVA Therapeutics B.V., an early clinical-stage biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced the…
POTOMAC, Md.–(BUSINESS WIRE)–#AD–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to proceed by the…
SUGAR LAND, Texas–(BUSINESS WIRE)–#biopharmaceutical–Non-profit research organization Hope Biosciences Stem Cell Research Foundation (HBSCRF) gained Federal Drug Administration (FDA) authorization Friday for the nation’s first stem cell study design…
DUBLIN–(BUSINESS WIRE)–The “Global Hepatitis B Virus (HBV) Market: 10 Year Demand Forecast & Impact of COVID-19 (2021-2030)” report has been added to ResearchAndMarkets.com’s offering.
The global hepatitis B virus (HBV) market is expected to rea…
DUBLIN–(BUSINESS WIRE)–The “Global Hepatitis B Virus (HBV) Market: 10 Year Demand Forecast & Impact of COVID-19 (2021-2030)” report has been added to ResearchAndMarkets.com’s offering.
The global hepatitis B virus (HBV) market is expected to rea…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…